1
|
Lou Z, Wang L, Yu K, Wei Q, Hussain T, Xia X, Zhou H. Electrospun PVB/AVE NMs as mask filter layer for win-win effects of filtration and antibacterial activity. J Memb Sci 2023; 672:121473. [PMID: 36785656 PMCID: PMC9908571 DOI: 10.1016/j.memsci.2023.121473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Revised: 02/05/2023] [Accepted: 02/07/2023] [Indexed: 02/11/2023]
Abstract
The COVID-19 pandemic has caused serious social and public health problems. In the field of personal protection, the facial masks can prevent infectious respiratory diseases, safeguard human health, and promote public safety. Herein, we focused on preparing a core filter layer for masks using electrospun polyvinyl butyral/apocynum venetum extract nanofibrous membranes (PVB/AVE NMs), with durable interception efficiency and antibacterial properties. In the spinning solution, AVE acted as a salt to improve electrical conductivity, and achieve long-lasting interception efficiency with adjustable pore size. It also played the role of an antibacterial agent in PVB/AVE NMs to achieve win-win effects. The hydrophobicity of PVB-AVE-6% was 120.9° whereas its filterability reached 98.3% when the pressure drop resistance was 142 Pa. PVB-AVE-6% exhibited intriguing properties with great antibacterial rates of 99.38% and 98.96% against S. aureus and E. coli, respectively. After a prolonged usability test of 8 h, the filtration efficiency of the PVB/AVE masks remained stable at over 97.7%. Furthermore, the antibacterial rates of the PVB/AVE masks on S. aureus and E. coli were 96.87% and 96.20% respectively, after using for 2 d. These results indicate that PVB/AVE NMs improve the protective performance of ordinary disposable masks, which has certain application in air filtration.
Collapse
Key Words
- AVE, apocynum venetum extract
- Air filtration
- Antibacterial properties
- Apocynum venetum extract
- CNF, cellulose nanofibres
- PA, polyamide
- PAN, polyacrylonitrile
- PLA, poly(lactic acid)
- PVB, polyvinyl butyral
- PVB/AVE NMs, polyvinyl butyral/apocynum venetum extract nanofibrous membranes
- PVDF, polyvinylidene fluoride
- Protective masks
- QF, quality factor
- WCA, water contact angle
- Win-win effects
Collapse
Affiliation(s)
- Zhuyushuang Lou
- College of Textile and Clothing, Xinjiang University, Xinjiang, Urumchi, 830046, China
| | - Ling Wang
- College of Textile and Clothing, Xinjiang University, Xinjiang, Urumchi, 830046, China
| | - Kefei Yu
- College of Textile and Clothing, Xinjiang University, Xinjiang, Urumchi, 830046, China
| | - Qufu Wei
- Key Laboratory of Eco-Textiles, Ministry of Education, Jiangnan University, Wuxi, Jiangsu, 214122, China
| | - Tanveer Hussain
- Textile Processing Department, Faculty of Engineering & Technology, National Textile University, Sheikhupura Road, Faisalabad, 37610, Pakistan
| | - Xin Xia
- College of Textile and Clothing, Xinjiang University, Xinjiang, Urumchi, 830046, China,Corresponding author
| | - Huimin Zhou
- College of Textile and Clothing, Xinjiang University, Xinjiang, Urumchi, 830046, China,Corresponding author
| |
Collapse
|
2
|
Wang X, Mohammad IS, Fan L, Zhao Z, Nurunnabi M, Sallam MA, Wu J, Chen Z, Yin L, He W. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B 2021; 11:2585-2604. [PMID: 34522599 PMCID: PMC8424280 DOI: 10.1016/j.apsb.2021.04.010] [Citation(s) in RCA: 47] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 02/18/2021] [Accepted: 03/15/2021] [Indexed: 12/11/2022] Open
Abstract
Invasive fungal infections (IFIs) represent a growing public concern for clinicians to manage in many medical settings, with substantial associated morbidities and mortalities. Among many current therapeutic options for the treatment of IFIs, amphotericin B (AmB) is the most frequently used drug. AmB is considered as a first-line drug in the clinic that has strong antifungal activity and less resistance. In this review, we summarized the most promising research efforts on nanocarriers for AmB delivery and highlighted their efficacy and safety for treating IFIs. We have also discussed the mechanism of actions of AmB, rationale for treating IFIs, and recent advances in formulating AmB for clinical use. Finally, this review discusses some practical considerations and provides recommendations for future studies in applying AmB for combating IFIs.
Collapse
Key Words
- ABCD, AmB colloidal dispersion
- AIDS, acquired immunodeficiency syndrome
- AP, antisolvent precipitation
- ARDS, acute respiratory distress syndrome
- AmB, amphotericin B
- AmB-GCPQ, AmB-encapsulated N-palmitoyl-N-methyl-N,N-dimethyl-N,N,N-trimethyl-6-O-glycol-chitosan nanoparticles
- AmB-IONP, AmB-loaded iron oxide nanoparticles
- AmB-PM, AmB-polymeric micelles
- AmB-SD, AmB sodium deoxycholate
- AmBd, AmB deoxycholate
- Amphotericin B
- Aspergillus fumigatus, A. fumigatus
- BBB, blood‒brain barrier
- BCS, biopharmaceutics classification system
- BDDE, butanediol diglycidyl ether
- BSA, bovine serum albumin
- BUN, blood urea nitrogen
- C. Albicans, Candida Albicans
- CFU, colony-forming unit
- CLSM, confocal laser scanning microscope
- CMC, carboxymethylated l-carrageenan
- CP, chitosan-polyethylenimine
- CS, chitosan
- Conjugates
- DDS, drug delivery systems
- DMPC, dimyristoyl phosphatidyl choline
- DMPG, dimyristoyl phosphatidylglycerole
- DMSA, dimercaptosuccinic acid
- Drug delivery
- GNPs, gelatin nanoparticles
- HPH, high-pressure homogenization
- HPMC, hydroxypropyl methylcellulose
- ICV, intensive care unit
- IFIs, invasive fungal infections
- Invasive fungal infections
- L-AmB, liposomal AmB
- LNA, linolenic acid
- MAA, methacrylic acid
- MFC, minimum fungicidal concentrations
- MIC, minimum inhibitory concentration
- MN, microneedles
- MOP, microneedle ocular patch
- MPEG-PCL, monomethoxy poly(ethylene glycol)-poly(epsilon-caprolactone)
- NEs, nanoemulsions
- NLC, nanostructured lipid carriers
- NPs, nanoparticles
- Nanoparticles
- P-407, poloxamer-407
- PAM, polyacrylamide
- PCL, polycaprolactone
- PDA, poly(glycolic acid)
- PDLLA, poly(d,l-lactic acid)
- PDLLGA, poly(d,l-lactic-co-glycolic acid)
- PEG, poly(ethylene glycol)
- PEG-DSPE, PEG-lipid poly(ethylene glycol)-distearoylphosphatidylethanolamine
- PEG-PBC, phenylboronic acid-functionalized polycarbonate/PEG
- PEG-PUC, urea-functionalized polycarbonate/PEG
- PGA-PPA, poly(l-lysine-b-l-phenylalanine) and poly(l-glutamic acid-b-l-phenylalanine)
- PLA, poly(lactic acid)
- PLGA, polyvinyl alcohol poly(lactic-co-glycolic acid)
- PLGA-PLH-PEG, PLGA-b-poly(l-histidine)-b-poly(ethylene glycol)
- PMMA, poly(methyl methacrylate)
- POR, porphyran
- PVA, poly(vinyl alcohol)
- PVP, polyvinylpyrrolidone
- Poor water-solubility
- RBCs, red blood cells
- RES, reticuloendothelial system
- ROS, reactive oxygen species
- SEM, scanning electron microscope
- SL-AmB, sophorolipid-AmB
- SLNs, solid lipid nanoparticles
- Topical administration
- Toxicity
- γ-CD, γ-cyclodextrin
- γ-PGA, γ-poly(gamma-glutamic acid
Collapse
Affiliation(s)
- Xiaochun Wang
- Department of Pharmaceutics, China Pharmaceutical University, Nanjing 211198, China
| | - Imran Shair Mohammad
- School of Pharmaceutical Sciences, Sun Yat-sen University, University Town, Guangzhou 510006, China
| | - Lifang Fan
- Jiangsu Aosaikang Pharmaceutical Co., Ltd., Nanjing 211112, China
| | - Zongmin Zhao
- School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA
| | - Md Nurunnabi
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, TX 79902, USA
| | - Marwa A. Sallam
- Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt
| | - Jun Wu
- Department of Geriatric Cardiology, Jiangsu Provincial Key Laboratory of Geriatrics, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - Zhongjian Chen
- Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China
| | - Lifang Yin
- Department of Pharmaceutics, China Pharmaceutical University, Nanjing 211198, China
| | - Wei He
- Department of Pharmaceutics, China Pharmaceutical University, Nanjing 211198, China
| |
Collapse
|
3
|
Petre A, Balta C, Herman H, Gharbia S, Codreanu A, Onita-Mladin B, Anghel-Zurbau N, Hermenean AG, Ignat SR, Dinescu S, Urzica I, Drafta S, Oancea L, Hermenean A. A novel experimental approach to evaluate guided bone regeneration (GBR) in the rat femur using a 3D-printed CAD/CAM zirconia space-maintaining barrier. J Adv Res 2020; 28:221-229. [PMID: 33364058 PMCID: PMC7753221 DOI: 10.1016/j.jare.2020.07.012] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Revised: 07/20/2020] [Accepted: 07/20/2020] [Indexed: 01/06/2023] Open
Abstract
Introduction Obtaining a certain bone volume is an important goal in implantology or orthopedics. Thus, after tooth extraction, quite a lot of horizontal and vertical alveolar bone is lost in time and can be detrimental to the implant treatment outcome, while the treatment of critical bone defects is a considerable challenge for surgery. Objectives In this study we designed a new in vivo model as an useful experimental tool to assess guided bone regeneration (GBR) using a computer-aided design/manufacturing (CAD-CAM) space-maintaining barrier. Methods The barrier was 3D printed with three progressive heights, surgically placed on rat femur, and GBR results were analyzed at 2, 4, and 8 weeks by X-ray and bone mineral density analysis, histology/morphometry and by immunofluorescence and immunohistochemistry for osteogenesis and angiogenesis evaluation. Results The obtained results show that the proposed experimental model provides a real-time useful information on progressive bone tissue formation, which depends on the volume of isolated space created for GBR and on molecular events that lead to satisfactory vertical and horizontal bone augmentation and osteointegration. Conclusion In conclusion, the proposed customized three-dome space-maintaining barrier is suitable as an experimental tool to assess the potential of using the designed barriers in dentistry and orthopedics to promote the formation of new bone and determine their space- and time-dependent limitations. Meanwhile, guided bone augmentation for dentistry requires subsequent evaluation on an alveolar bone preclinical model followed by clinical implementation.
Collapse
Key Words
- Bioengineering
- Bone regeneration
- Bone remodeling
- CAD/CAM, computer-aided design/computer-aided manufacturing
- DAPI, 4′,6-diamidino-2-phenylindole
- Dentistry
- FBS, fetal bovine serum
- GAPDH, glyceraldehyde 3-phosphate dehydrogenase
- GBR, guided bone regeneration
- Guided tissue regeneration
- IVC, individually ventilated cage
- OCN, osteocalcin
- OPN, osteopontin
- OSX, osterix
- Orthodontics
- PBS, phosphate-buffered saline
- PCL, poly(e-caprolactone)
- PDGFRβ, platelet-derived growth factor receptor β
- PFA, paraformaldehyde
- PGA, poly(glycolic acid)
- PLA, poly(lactic acid)
- VEGF, vascular endothelial growth factor
- VEGFR, vascular endothelial growth factor receptor
- Zirconia
- ePTFE, expanded polytetrafluoroethylene
Collapse
Affiliation(s)
- Alexandru Petre
- Occlusion and Fixed Prosthodontic Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - Cornel Balta
- "Aurel Ardelean" Institute of Life Sciences, Vasile Goldis Western University of Arad, Romania
| | - Hildegard Herman
- "Aurel Ardelean" Institute of Life Sciences, Vasile Goldis Western University of Arad, Romania
| | - Sami Gharbia
- "Aurel Ardelean" Institute of Life Sciences, Vasile Goldis Western University of Arad, Romania.,Department of Biochemistry and Molecular Biology, University of Bucharest, Romania
| | - Ada Codreanu
- Department of Histology, Faculty of Medicine, Vasile Goldis Western University of Arad, Romania
| | - Bianca Onita-Mladin
- "Aurel Ardelean" Institute of Life Sciences, Vasile Goldis Western University of Arad, Romania
| | - Nicoleta Anghel-Zurbau
- Department of Histology, Faculty of Medicine, Vasile Goldis Western University of Arad, Romania
| | - Andrei-Gelu Hermenean
- Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - Simona-Rebeca Ignat
- Department of Biochemistry and Molecular Biology, University of Bucharest, Romania
| | - Sorina Dinescu
- Department of Biochemistry and Molecular Biology, University of Bucharest, Romania
| | - Iuliana Urzica
- National Institute for Lasers, Plasma and Radiation Physics, Lasers Department, Bucharest, Romania
| | - Sergiu Drafta
- Occlusion and Fixed Prosthodontic Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - Luminita Oancea
- Occlusion and Fixed Prosthodontic Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - Anca Hermenean
- "Aurel Ardelean" Institute of Life Sciences, Vasile Goldis Western University of Arad, Romania.,Department of Histology, Faculty of Medicine, Vasile Goldis Western University of Arad, Romania.,Department of Biochemistry and Molecular Biology, University of Bucharest, Romania
| |
Collapse
|
4
|
Zhang M, Matinlinna JP, Tsoi JKH, Liu W, Cui X, Lu WW, Pan H. Recent developments in biomaterials for long-bone segmental defect reconstruction: A narrative overview. J Orthop Translat 2020; 22:26-33. [PMID: 32440496 DOI: 10.1016/j.jot.2019.09.005] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2019] [Revised: 08/19/2019] [Accepted: 09/09/2019] [Indexed: 12/15/2022] Open
Abstract
Reconstruction of long-bone segmental defects (LBSDs) has been one of the biggest challenges in orthopaedics. Biomaterials for the reconstruction are required to be strong, osteoinductive, osteoconductive, and allowing for fast angiogenesis, without causing any immune rejection or disease transmission. There are four main types of biomaterials including autograft, allograft, artificial material, and tissue-engineered bone. Remarkable progress has been made in LBSD reconstruction biomaterials in the last ten years. The translational potential of this article Our aim is to summarize recent developments in the divided four biomaterials utilized in the LBSD reconstruction to provide the clinicians with new information and comprehension from the biomaterial point of view.
Collapse
Key Words
- ADSC, allogenic adipose-derived stem cells
- ALLO, partially demineralized allogeneic bone block
- ALP, alkaline phosphatase
- ASC, adipose-derived stem cell
- Allograft
- Artificial material
- Autograft
- BMP-2 & 4, bone morphogenetic protein-2 & 4
- BMSC, bone marrow–derived mesenchymal stem cell
- BV, baculovirus
- Biomaterial
- CS, chitosan
- DBM, decalcified bone matrix
- FGF-2, Fibroblast Growth Factor-2
- HDB, heterogeneous deproteinized bone
- LBSD, long-bone segmental defect
- Long-bone segmental defect reconstruction
- M-CSF, macrophage colony-stimulating factor
- MIC, fresh marrow-impregnated ceramic block
- MSC, autologous mesenchymal stem cells
- PCL, polycaprolactone
- PDGF, Platelet-Derived Growth Factor
- PDLLA, poly(DL-lactide)
- PET/CT, positron emission- and computed tomography
- PLA, poly(lactic acid)
- PPF, propylene fumarate
- SF, silk fibroin
- TCP, tricalcium phosphate
- TEB, combining ceramic block with osteogenic-induced mesenchymal stem cells and platelet-rich plasma
- TGF-β, Transforming Growth Factor-β
- Tissue engineering
- VEGF, Vascular Endothelial Growth Factor
- bFGF, basic Fibroblast Growth Factor
- htMSCs, human tubal mesenchymal stem cells
- nHA, nano-hydroxyapatite
- poly, (L-lactide-co-D,L-lactide)
- rADSC, rabbit adipose-derived mesenchymal stem cell
- rVEGF-A, recombinant vascular endothelial growth factor-A
- rhBMP-2, recombinant human bone morphogenetic protein-2
- rhBMP-7, recombinant human bone morphogenetic protein 7
- sRANKL, soluble RANKL
- β-TCP, β-tricalcium phosphate
Collapse
|
5
|
Tao J, Chow SF, Zheng Y. Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles. Acta Pharm Sin B 2019; 9:4-18. [PMID: 30766774 PMCID: PMC6361851 DOI: 10.1016/j.apsb.2018.11.001] [Citation(s) in RCA: 90] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Revised: 11/02/2018] [Accepted: 11/04/2018] [Indexed: 01/08/2023] Open
Abstract
Nanoparticles are considered to be a powerful approach for the delivery of poorly water-soluble drugs. One of the main challenges is developing an appropriate method for preparation of drug nanoparticles. As a simple, rapid and scalable method, the flash nanoprecipitation (FNP) has been widely used to fabricate these drug nanoparticles, including pure drug nanocrystals, polymeric micelles, polymeric nanoparticles, solid lipid nanoparticles, and polyelectrolyte complexes. This review introduces the application of FNP to produce poorly water-soluble drug nanoparticles by controllable mixing devices, such as confined impinging jets mixer (CIJM), multi-inlet vortex mixer (MIVM) and many other microfluidic mixer systems. The formation mechanisms and processes of drug nanoparticles by FNP are described in detail. Then, the controlling of supersaturation level and mixing rate during the FNP process to tailor the ultrafine drug nanoparticles as well as the influence of drugs, solvent, anti-solvent, stabilizers and temperature on the fabrication are discussed. The ultrafine and uniform nanoparticles of poorly water-soluble drug nanoparticles prepared by CIJM, MIVM and microfluidic mixer systems are reviewed briefly. We believe that the application of microfluidic mixing devices in laboratory with continuous process control and good reproducibility will be benefit for industrial formulation scale-up.
Collapse
Key Words
- ACN, acetonitrile
- CA 320S Seb, cellulose acetate 320S sebacate
- CAP Adp 0.33, cellulose acetate propionate 504-0.2 adipate 0.33
- CAP Adp 0.85, cellulose acetate propionate adipate 0.85
- CFA, cefuroxime axetil
- CIJM, confined impinging jets mixer
- CMCAB, carboxymethyl cellulose acetate butyrate
- CTACl, cetyltrimethylammonium chloride
- DMF, dimethyl formamide
- DMSO, dimethyl sulfoxide
- DSPE-PEG, distearyl phosphatidyl ethanolamine-poly(ethylene glycol)
- Dex-PLLA, dextrose-poly(l-lactic acid)
- FNP, flash nanoprecipitation
- Flash nanoprecipitation
- HPC, hydroxypropyl cellulose
- HPMC, hydroxypropyl methyl cellulose
- HPMCAS, hydroxypropyl methylcellulose acetate succinate
- MIVM, multi-inlet vortex mixer
- Microfluidic mixer device
- NaAlg, sodium alginate
- NaCMC, carboxymethyl cellulose sodium
- Nanoparticles
- P(MePEGCA-co-HDCA), poly(methoxy polyethylene glycol cyanoacrylate-co-hexadecyl cyanoacrylate)
- PAA, poly(acrylic acid)
- PAH, polyallylamine hydrochloride
- PCL, poly(ε-caprolactone)
- PEG, polyethylene glycol
- PEG-PCL, poly(ethylene glycol)-poly(ε-caprolactone)
- PEG-PLA, poly(ethylene glycol)-poly(lactic acid)
- PEG-PLGA, poly(ethylene glycol)-poly(lactic-co-glycolic acid)
- PEG-PS, poly(ethylene glycol)-polystyrene
- PEI, polyethyleneimine
- PEO-PDLLA, poly(ethylene oxide)-poly(d,l-lactic acid)
- PLA, poly(lactic acid)
- PLGA, poly(lactic-co-glycolic acid)
- PMMA, polymethyl methacrylate
- PSS, polyprotomine sulfate
- PVA, polyvinyl alcohol
- PVP, polyvinyl pyrrolidone
- Poorly water-soluble drug
- SDS, sodium dodecyl sulfonate
- SLS, sodium lauryl sulfate
- THF, tetrahydrofuran
- TPGS, tocopheryl polyethylene glycol 1000 succinate
- ε-PL, ε-polylysine
Collapse
Affiliation(s)
- Jinsong Tao
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Science, University of Macau, Macau, China
| | - Shing Fung Chow
- Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China
| | - Ying Zheng
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Science, University of Macau, Macau, China
| |
Collapse
|
6
|
B. Shekhawat P, B. Pokharkar V. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm Sin B 2017; 7:260-280. [PMID: 28540164 PMCID: PMC5430883 DOI: 10.1016/j.apsb.2016.09.005] [Citation(s) in RCA: 74] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Revised: 09/06/2016] [Accepted: 09/21/2016] [Indexed: 11/10/2022] Open
Abstract
Oral drug absorption is a process influenced by the physicochemical and biopharmaceutical properties of the drug and its inter-relationship with the gastrointestinal tract. Drug solubility, dissolution and permeability across intestinal barrier are the key parameters controlling absorption. This review provides an overview of the factors that affect drug absorption and the classification of a drug on the basis of solubility and permeability. The biopharmaceutical classification system (BCS) was introduced in early 90׳s and is a regulatory tool used to predict bioavailability problems associated with a new entity, thereby helping in the development of a drug product. Strategies to combat solubility and permeability issues are also discussed.
Collapse
Key Words
- ABC, ATP-binding cassette
- AP, absorption potential
- API, active pharmaceutical ingredient
- ATP, adenosine triphosphate
- AZT, azidothymidine
- BA/BE, bioavailability/bioequivalence
- BCRP, breast cancer resistance protein
- BCS
- BCS, biopharmaceutical classification system
- BDDS, biopharmaceutical drug disposition system
- BSP, bromosulfophthalein
- CD, cyclodextrin
- CDER, Centre for Drug Evaluation and Research
- CNT, Na+-dependent concentrative transporter
- CNT, concentrative nucleoside transporter
- CYP, cytochrome P450
- D:S, dose:solubility
- E217G, estradiol 17β-glucuronide
- EMEA, European Medicines Agency
- ENT, equilibrative nucleoside transporter
- FATP, fatty acid transporter protein
- FDA, U.S. Food and Drug Administration
- FIP, International Pharmaceutical Federation
- FaSSIF, fasted state simulated intestinal fluid
- Factors affecting absorption
- FeSSIF, fed state simulated intestinal fluid
- Formulation strategies
- GIS, gastrointestinal simulator
- GIT, gastrointestinal tract
- GITA, gastrointestinal transit and absorption
- GLUT, sodium-independent facilitated diffusion transporter
- GRAS, generally recognized as safe
- HIV, human immunodeficiency disease
- HPC-SL, LBDDS, lipid based drug delivery system
- HUGO, Human Genome Organization
- ICH, International Council of Harmonization
- IDR, intrinsic dissolution rate
- IR, immediate release
- ISBT, sodium dependent bile salt transporter
- MCT, monocarboxylate transporter
- MPP, 1-methyl-4-phenylpyridinium
- MRP, multidrug resistance associated protein
- NLC, nanostructured lipid carrier
- NME, new molecular entity
- NTCP, sodium-dependent taurocholate co-transporting polypeptide
- OAT, organic anion transporter
- OATP, organic anion transporting polypeptide
- OCT, organic cationic transporter
- OCTN, organic cationic/carnitine transporter
- OMM, ordered mesoporous material
- P-gp, P-glycoprotein
- PAH, p-aminohippurate
- PAMPA, parallel artificial membrane permeability assay
- PEG, polyethylene glycol
- PEI, polyethyleneimine
- PEPT, peptide transporter
- PGA, polyglycolic acid
- PLA, poly(lactic acid)
- PLGA, poly-d,l-lactide-co-glycoside
- PMAT, plasma membrane monoamine transport
- PSA, polar surface area
- PVDF, polyvinylidene difluoride
- Papp, apparent permeability
- Peff, effective permeability
- Permeability
- Psi, porous silicon
- RFC, reduced folate transporter
- SDS, sodium dodecyl sulphate
- SGLT, sodium dependent secondary active transporter
- SIF, simulated intestinal fluid
- SLC, solute carrier
- SLCO, solute carrier organic anion
- SLN, solid lipid nanoparticles
- SMVT, sodium dependent multivitamin transporter
- SPIP, single pass intestinal perfusion
- SUPAC, scale-up and post approval changes
- SVCT, sodium-dependent vitamin C transporter
- Solubility
- TEOS, tetraethylortho silicate
- UWL, unstirred water layer
- VDAD, volume to dissolve applied dose
- WHO, World Health Organization
- pMMA, polymethyl methacrylate
- vit. E TPGS, vitamin E tocopherol polyethylene glycol succinate
Collapse
|